Search the GHTC website

Global health R&D delivers for Maryland

US government investment in global health R&D has delivered

$2.5 billion
to Maryland research institutions
30,700+ new jobs
for Maryland
Global health R&D at work in Maryland

The University of Maryland has developed a vaccine, Vaxchora™, to protect US adults traveling to cholera-affected areas. Vaxchora is the only cholera vaccine available in the United States, and the only single-dose vaccine for cholera licensed anywhere. Acquired through contaminated food or water, cholera can kill in less than 24 hours if left untreated. Widespread in 69 countries, this highly contagious disease impacts millions of people worldwide each year.

  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Jobs created: Based on previous analysis of the economic impact of National Institutes of Health R&D funding and author's analysis described above. See methodology for additional details.
  • Case study photo: Maryland GovPics/JayBaker